Cite
Viral Rebound and Emergence of Drug Resistance in the Absence of Viral Load Testing: A Randomized Comparison between Zidovudine-Lamivudine plus Nevirapine and Zidovudine-Lamivudine plus Abacavir.
MLA
Ndembi, Nicasie, et al. “Viral Rebound and Emergence of Drug Resistance in the Absence of Viral Load Testing: A Randomized Comparison between Zidovudine-Lamivudine plus Nevirapine and Zidovudine-Lamivudine plus Abacavir.” Journal of Infectious Diseases, vol. 201, no. 1, Jan. 2010, pp. 106–13. EBSCOhost, https://doi.org/10.1086/648590.
APA
Ndembi, N., Goodall, R. L., Dunn, D. T., McCormick, A., Burke, A., Lyagoba, F., Munderi, P., Katundu, P., Kityo, C., Robertson, V., Yirrell, D. L., Walker, A. S., Gibb, D. M., Gilks, C. F., Kaleebu, P., & Pillay, D. (2010). Viral Rebound and Emergence of Drug Resistance in the Absence of Viral Load Testing: A Randomized Comparison between Zidovudine-Lamivudine plus Nevirapine and Zidovudine-Lamivudine plus Abacavir. Journal of Infectious Diseases, 201(1), 106–113. https://doi.org/10.1086/648590
Chicago
Ndembi, Nicasie, Ruth L. Goodall, David T. Dunn, Adele McCormick, Andy Burke, Fred Lyagoba, Paula Munderi, et al. 2010. “Viral Rebound and Emergence of Drug Resistance in the Absence of Viral Load Testing: A Randomized Comparison between Zidovudine-Lamivudine plus Nevirapine and Zidovudine-Lamivudine plus Abacavir.” Journal of Infectious Diseases 201 (1): 106–13. doi:10.1086/648590.